用阳性和阴性症状量表（PANSS）评定患者的精神症状及严重程度。
Mental symptoms and the severity of the disease were evaluated with positive and negative syndrome scale(PANSS).
于治疗前、出院1年后采用阳性和阴性症状量表(PANSS)及生活质量量表(WHOQOL - 100)进行精神症状和生活质量的评定。
All the patients were evaluated with the positive and negative symptoms scale (PANSS) and WHO Quality of Life Survey (WHOQOL 100) before treatment and 1 year after discharge.
并用阳性和阴性症状量表(PANSS)评定患者的精神症状。
Psychiatric symptoms were assessed by Positive and Negative Syndrome Scale (PANSS).
采用阳性症状量表和阴性症状量表(PANSS)以评定齐拉西酮对女性精神分裂症的疗效，采用不良反应量表(TESS)评定该药物的副反应。
The positive and negative symptom scale (PANSS) is adopted to appraise the curative effect, and the treatment emergent symptom scale (TESS) is adopted to appraise by-reaction.
采用阳性症状量表和阴性症状量表(PANSS)以评定齐拉西酮对女性精神分裂症的疗效，采用不良反应量表(TESS)评定该药物的副反应。
The positive and negative symptom scale (PANSS) is adopted to appraise the curative effect, and the treatment emergent symptom scale (TESS) is adopted to appraise by-reaction.
应用推荐